Discover 1,187 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,187
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
for
Narcolepsy Type 2
Location: Cincinnati OH, Novi MI, Huntersville NC, Toronto,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07502443
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
for
Narcolepsy Type 1
Location: Cincinnati OH, Novi MI, Lansing MI, St Louis MO,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07455383
Phase 3, Recruiting
A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
for
Narcolepsy Type 1
Location: Cincinnati OH, Miami FL
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT07633301
Phase 2, Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
for
Narcolepsy Type 1
Location: Cincinnati OH, Lansing MI, St Louis MO, Toronto,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07540897
Phase 3, Recruiting
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
Location: Cincinnati OH, Ann Arbor MI, Cleveland OH, Chicago IL,
Sponsor: Endospan Ltd.
Sex: All
Age: 18+
Code: NCT04471909
Recruiting
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Cincinnati OH, Peoria IL, Milwaukee WI, St Louis MO,
Sponsor: Cytokinetics
Sex: All
Age: 40 - 70+
Code: NCT06793371
Phase 2, Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
for
Narcolepsy Type 2
Location: Cincinnati OH, Cleveland OH, Lathrup Village MI,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06952699
Phase 2, Recruiting
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Cincinnati OH, Grand Rapids MI, Tampa FL,
Sponsor: Hanmi Pharmaceutical Company Limited
Sex: All
Age: 18+
Code: NCT06234397
Phase 1, Recruiting
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Cincinnati OH, Louisville KY, Elkhart IN, Cleveland OH,
Sponsor: Kardigan, Inc.
Sex: All
Age: 50+
Code: NCT07001800
Phase 2, Phase 3, Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for
Acute Decompensated Heart Failure
Location: Cincinnati OH, Columbus OH, Louisville KY, Ann Arbor MI,
Sponsor: Reprieve Cardiovascular, Inc
Sex: All
Age: 22+
Code: NCT06898515
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Cincinnati OH, Columbus OH, Charleston WV, Ann Arbor MI,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
for
Ventricular Arrythmia, Ventricular Fibrillation,
Location: Cincinnati OH, Lexington KY, Glenview IL,
Sponsor: AtaCor Medical, Inc.
Sex: All
Age: 18+
Code: NCT07324031
Recruiting
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for
Symptomatic Genetic Dilated Cardiomyopathy
Location: Cincinnati OH, Columbus OH, Detroit MI, Chicago IL,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07210723
Phase 2, Phase 3, Recruiting
Virtue® SAB in the Treatment of Coronary ISR Trial
for
Coronary Artery Disease
Location: Cincinnati OH, Indianapolis IN, Royal Oak MI,